OVERVIEW

We invite you to join us for the 1st Annual Best of GI Cancer conference. This innovative and state of the art program is set completely in a multidisciplinary tumor board environment with some of the world's leading gastrointestinal cancer experts to discuss a variety of real-world cases —all while incorporating data from the major oncologic annual meetings. Expert panelists include surgeons, medical oncologists, radiation oncologists, radiologists, pathologists, integrative medicine specialists, endocrinologists, geneticists, and patient advocates.

​LEARNING OBJECTIVES

• Review and analyze the latest therapeutic advances for the treatment and management of GI cancer as presented and explored at ASCO GI 2023
• Apply new data and therapeutic advances into guideline-driven treatment strategies to improve the care of patients with GI cancers, neuroendocrine tumors, and hepatocellular cancers
• Identify subpopulations of patients with gastrointestinal cancers most likely to benefit from a specific treatment plan based on prognostic or predictive markers
• Evaluate the role of ctDNA and MRD in GI cancers

ACCREDITATION

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health Conferencing.  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME). 

Amedco LLC designates this live activity for a maximum of 8.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

For more information please visit the official event page.